Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG-010 in relapsed or refractory DLBCL (China, phase II)
CTR20190882Phase 2Completed
- Sponsor
- Karyopharm Therapeutics Inc.
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in diffuse large B-cell lymphoma (DLBCL), sponsored by Karyopharm Therapeutics Inc.. Started Jul 2019; status: completed.
02
Drugs
selinexor
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on CTR20190882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190882.